
NIIMBL accelerates biopharmaceutical innovation, develops efficient manufacturing standards, and trains a leading workforce.
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) was founded as a public-private partnership with the core mission to accelerate biopharmaceutical innovation, develop efficient manufacturing standards, and train a world-leading biopharmaceutical manufacturing workforce. As part of Manufacturing USA®, NIIMBL focuses on advancing U.S. competitiveness in the biopharmaceutical industry through various programs, including vaccine manufacturing, viral vectors, and process intensification.
NIIMBL's notable affiliates include a diverse network of industry leaders, academic institutions, and government entities. The organization has garnered significant investments and support from both public and private sectors. Key achievements include the development of industry standards that streamline manufacturing processes and the establishment of educational programs that equip the workforce with cutting-edge skills. NIIMBL's impact is evident in its contribution to making biopharmaceutical manufacturing more efficient and innovative, thereby enhancing the industry's overall growth and sustainability.
Niimbl's most recent funding round was for $10M (USD) in October 2023.
As of Oct 3, 2023, Niimbl has disclosed funding of $163M (USD).

BioMADE
biomade.org

Resilience
resilience.com

BiotechInnova
biotechinnova.com

NeuImmune
neuimmune.com

Bright Path Laboratories
brightpath.inc

Nimbus Therapeutics
nimbustx.com

Novartis Institutes For Biomedical Research
novartis.com
ImCare Biotech

NouBio
noubio.co

KBI Biopharma
kbibiopharma.com

NJ Bio
njbio.com

Innovation Pharmaceuticals
ipharminc.com
Center for Breakthrough Medicines
Nexeption
Jlabs

NGM Biopharmaceuticals
ngmbio.com
NBI Development

PIN Pharma
pinpharma.com

New Horizon Biotech

The Blinc Group
theblincgroup.com